Encenicline: Phase III data

By WIR Staff | Apr 4, 2016 | 7:00 AM GMT

Top-line data from over 1,500 schizophrenics in a pair of double-blind, international Phase III trials showed that once-daily oral encenicline added to chronic stable atypical antipsychotic therapy

Read the full 271 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE